Yoko Satoh, Masami Kawamoto, Kazunori Kubota, Koji Murakami, Makoto Hosono, Michio Senda, Masayuki Sasaki, Toshimitsu Momose, Kengo Ito, Terue Okamura, Keiichi Oda, Yuji Kuge, Minoru Sakurai, Ukihide Tateishi, Yasuhisa Fujibayashi, Yasuhiro Magata, Takeshi Yoshida, Atsuo Waki, Katsuhiko Kato, Teisuke Hashimoto, Mayuki Uchiyama, Seigo Kinuya, Tatsuya Higashi, Yasuhiro Magata, Akihiro Machitori, Hirotaka Maruno, Ryogo Minamimoto, Keiichiro Yoshinaga
Annals of nuclear medicine 35(3) 406-414 2021年3月 筆頭著者
Breast positron emission tomography (PET) has had insurance coverage when performed with conventional whole-body PET in Japan since 2013. Together with whole-body PET, accurate examination of breast cancer and diagnosis of metastatic disease are possible, and are expected to contribute significantly to its treatment planning. To facilitate a safer, smoother, and more appropriate examination, the Japanese Society of Nuclear Medicine published the first edition of practice guidelines for high-resolution breast PET in 2013. Subsequently, new types of breast PET have been developed and their clinical usefulness clarified. Therefore, the guidelines for breast PET were revised in 2019. This article updates readers as to what is new in the second edition. This edition supports two different types of breast PET depending on the placement of the detector: the opposite-type (positron emission mammography; PEM) and the ring-shaped type (dedicated breast PET; dbPET), providing an overview of these scanners and appropriate imaging methods, their clinical applications, and future prospects. The name "dedicated breast PET" from the first edition is widely used to refer to ring-shaped type breast PET. In this edition, "breast PET" has been defined as a term that refers to both opposite- and ring-shaped devices. Up-to-date breast PET practice guidelines would help provide useful information for evidence-based breast imaging.